Table 1.
Study | Factors |
---|---|
DASfree [17] |
Older age First-line therapy Longer treatment duration |
ENESTop [43] | Longer MR4.5 duration prior to discontinuation |
LAST [10••] |
Undetectable BCR-ABL RQ-PCR at 3 months after discontinuation Undetectable BCR-ABL1 by digital PCR at time of discontinuation |
DESTINY [20•] |
Longer treatment duration MR4 group (all BCR-ABL1 measurements after dose reduction < 0.01%) |
EURO-SKI [12••] |
Longer treatment duration Longer MR4 duration prior to discontinuation |
STIM [44] |
Low-risk Sokal Longer treatment duration |
ISAV [18] |
Older age Undetectable BCR-ABL1 by digital PCR at time of discontinuation |